PPW
ABBV icon

Parcion Private Wealth’s AbbVie ABBV Stock Holding History

Parcion Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79M Sell
15,052
-1,135
-7% -$244K 0.21% 82
2026
Q1 		$3.52M Sell
16,187
-431
-3% -$95.6K 0.22% 82
2025
Q4 		$3.8M Buy
16,618
+103
+0.6% +$23.5K 0.23% 78
2025
Q3 		$3.82M Buy
16,515
+868
+6% +$177K 0.24% 77
2025
Q2 		$2.9M Buy
15,647
+41
+0.3% +$7.62K 0.21% 77
2025
Q1 		$3.27M Buy
15,606
+1,125
+8% +$219K 0.27% 73
2024
Q4 		$2.57M Sell
14,481
-16
-0.1% -$2.94K 0.2% 78
2024
Q3 		$2.86M Buy
14,497
+2,693
+23% +$503K 0.24% 71
2024
Q2 		$2.02M Buy
11,804
+950
+9% +$157K 0.19% 86
2024
Q1 		$1.98M Buy
10,854
+20
+0.2% +$3.45K 0.17% 88
2023
Q4 		$1.68M Sell
10,834
-143
-1% -$20.8K 0.15% 88
2023
Q3 		$1.64M Buy
10,977
+287
+3% +$42.1K 0.17% 88
2023
Q2 		$1.44M Hold
10,690
– – 0.15% 92
2023
Q1 		$1.7M Buy
10,690
+55
+0.5% +$8.41K 0.18% 85
2022
Q4 		$1.72M Hold
10,635
– – 0.19% 87
2022
Q3 		$1.43M Sell
10,635
-63
-0.6% -$9.04K 0.16% 100
2022
Q2 		$1.59M Buy
10,698
+109
+1% +$16.7K 0.16% 106
2022
Q1 		$1.74M Sell
10,589
-551
-5% -$80K 0.16% 93
2021
Q4 		$1.51M Sell
11,140
-1,454
-12% -$172K 0.14% 92
2021
Q3 		$1.38M Buy
12,594
+223
+2% +$25.5K 0.12% 104
2021
Q2 		$1.39M Hold
12,371
– – 0.14% 101
2021
Q1 		$1.34M Hold
12,371
– – 0.15% 103
2020
Q4 		$1.33M Hold
12,371
– – 0.18% 91
2020
Q3 		$1.06M Hold
12,371
– – 0.16% 94
2020
Q2 		$1.23M Sell
12,371
-31
-0.2% -$2.73K 0.21% 75
2020
Q1 		$945K Buy
12,402
+223
+2% +$19K 0.26% 71
2019
Q4 		$1.08M Buy
+12,179
New +$1.01M 0.24% 71

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parcion Private Wealth's ABBV Position: Q2 2026 in Review

Parcion Private Wealth reduced its AbbVie (ABBV) stake by 7% in Q2 2026, selling an estimated $244K and leaving 15,052 shares worth $3.79M. The position accounts for 0.21% of the portfolio, ranked #82.

Parcion Private Wealth first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.82M in Q3 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Parcion Private Wealth held 15,052 shares of AbbVie worth $3.79M as of Q2 2026.
  • Parcion Private Wealth sold 1,135 AbbVie shares in Q2 2026, an estimated $244K.
  • AbbVie made up 0.21% of Parcion Private Wealth's portfolio in Q2 2026, its #82 holding.
  • Parcion Private Wealth first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Parcion Private Wealth's AbbVie position peaked at $3.82M in Q3 2025.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Parcion Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.